{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:18:14Z","timestamp":1789503494249,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118451","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:03Z","timestamp":1788995223000},"page":"118451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K\/AKT signaling and metabolic homeostasis"],"prefix":"10.1016","volume":"254","author":[{"given":"Ramya Ranjan Nayak","family":"S P","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangaraj","family":"Devadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vellapandian","family":"Chitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader O.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhlid H.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamuralikrishnan","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariadhas Valan","family":"Arasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathiravan Muthu","family":"Kumaradoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Karthick","family":"Raja Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesu","family":"Arockiaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118451_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bcp.2026.118451_b0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.118451_b0015","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2026.118451_b0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2018","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bcp.2026.118451_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antiox10020270","article-title":"Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review","volume":"10","author":"Rinaldi","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2026.118451_b0035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/liv.15930","article-title":"The first MASH drug therapy on the horizon: current perspectives of resmetirom","volume":"44","author":"Petta","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2026.118451_b0040","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-015-0437-3","article-title":"Non-alcoholic steatohepatitis: limited available treatment options but promising drugs in development and recent progress towards a regulatory approval pathway","volume":"75","author":"Filozof","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2026.118451_b0045","doi-asserted-by":"crossref","DOI":"10.2174\/1573407213666161214162149","article-title":"The role of oxazolidine derivatives in the treatment of infectious and chronic diseases","volume":"13","author":"Branco-Junior","year":"2017","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.bcp.2026.118451_b0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/138955707780363783","article-title":"The contribution of oxazolidinone frame to the biological activity of pharmaceutical drugs and natural products","volume":"7","author":"Zappia","year":"2007","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118451_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.22270\/jddt.v13i1.5719","article-title":"Synthesis, characterization, and anti-inflammatory activity of some novel oxazole derivatives","volume":"13","author":"Garg","year":"2023","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.bcp.2026.118451_b0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bcp.2026.118451_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70312","article-title":"Therapeutic potential of methylindoline derivative in ameliorating cadmium\u2010induced nephritis experimented in zebrafish model","volume":"39","author":"Nayak","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bcp.2026.118451_b0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.procbio.2024.04.012","article-title":"Furan-based chalcone protects \u03b2-cell damage and improves glucose uptake in alloxan-induced zebrafish diabetic model via influencing peroxisome proliferator-activated receptor agonists (PPAR-\u03b3) signaling","volume":"142","author":"Nayak","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.bcp.2026.118451_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106968","article-title":"A novel brominated chalcone derivative as a promising multi-target inhibitor against multidrug-resistant Listeria monocytogenes","volume":"196","author":"Haridevamuthu","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bcp.2026.118451_b0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ame2.12309","article-title":"Establishment of a non\u2010alcoholic fatty liver disease model by high fat diet in adult zebrafish","volume":"7","author":"Li","year":"2024","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.bcp.2026.118451_b0085","doi-asserted-by":"crossref","DOI":"10.3791\/61935","article-title":"Alternate immersion in glucose to produce prolonged hyperglycemia in Zebrafish","author":"McCarthy","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bcp.2026.118451_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175605","article-title":"Hepatoprotective effect of dihydroxy piperlongumine in high cholesterol-induced non-alcoholic fatty liver disease zebrafish via antioxidant activity","volume":"945","author":"Haridevamuthu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118451_b0095","first-page":"546","article-title":"A multi-site assessment of anesthetic overdose, hypothermic shock, and electrical stunning as methods of Euthanasia for Zebrafish (Danio rerio) embryos and larvae","volume":"11","author":"Mocho","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bcp.2026.118451_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114917","article-title":"Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model","volume":"192","author":"Nayak","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2026.118451_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116917","article-title":"Indole-3 acetic acid induced cardiac hypertrophy in Wistar albino rats","volume":"486","author":"Nayak","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118451_b0110","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.3390\/ijms24087044","article-title":"CIGB-258 exerts potent anti-inflammatory activity against carboxymethyllysine-induced acute inflammation in hyperlipidemic zebrafish via the protection of apolipoprotein A-I","volume":"24","author":"Cho","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0115","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.3390\/ijms222011128","article-title":"The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease","volume":"22","author":"Ziolkowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/antiox13070797","article-title":"The role of antioxidants in the treatment of metabolic dysfunction-associated fatty liver disease: a systematic review","volume":"13","author":"Mohammadian","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2026.118451_b0125","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non\u2010alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur. J. Sport Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0130","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/ars.2009.3058","article-title":"Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities","volume":"15","author":"Gambino","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.118451_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01857","article-title":"Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes","volume":"9","author":"Teodoro","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.118451_b0140","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118451_b0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/nu9020096","article-title":"Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2026.118451_b0150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/liv.15601","article-title":"Zebrafish facilitate non\u2010alcoholic fatty liver disease research: tools, models and applications","volume":"43","author":"Chang","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2026.118451_b0155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/ph17081073","article-title":"Unlocking cholesterol metabolism in metabolic-associated steatotic liver disease: molecular targets and natural product interventions","volume":"17","author":"Li","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2026.118451_b0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ijms20020298","article-title":"Homeostasis of glucose and lipid in non-alcoholic fatty liver disease","volume":"20","author":"Chao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0165","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms23073897","article-title":"Viral hepatitis, cholesterol metabolism, and cholesterol-lowering natural compounds","volume":"23","author":"Liou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118451_b0170","doi-asserted-by":"crossref","first-page":"82621","DOI":"10.18632\/oncotarget.19734","article-title":"Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118451_b0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP\u20101c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2026.118451_b0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/toxins14120833","article-title":"MC-LR aggravates liver lipid metabolism disorders in obese mice fed a high-fat diet via PI3K\/AKT\/mTOR\/SREBP1 signaling pathway","volume":"14","author":"Chu","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bcp.2026.118451_b0185","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/S1751731116000380","article-title":"Effects of inhibiting PI3K-akt-mTOR pathway on lipid metabolism homeostasis in goose primary hepatocytes","volume":"10","author":"Liu","year":"2016","journal-title":"Animal"},{"key":"10.1016\/j.bcp.2026.118451_b0190","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of liver diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol. Biol. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:48:15Z","timestamp":1789501695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S0006295226007902"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118451","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K\/AKT signaling and metabolic homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118451"}}